Premium
The possibility of prenatal diagnosis by gene dosage: Confirmation of duplication 10q24→qter from Got‐l activity in fetal erythrocytes
Author(s) -
Dallapiccola B.,
Pachì A.,
Ferranti G.,
Micara G.,
Magnani M.,
Dachà M.
Publication year - 1981
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.1970010306
Subject(s) - fetus , prenatal diagnosis , gene , gene dosage , gestation , gene duplication , locus (genetics) , gene product , gestational age , abortion , andrology , biology , genetics , obstetrics , medicine , pregnancy , gene expression
The activity of four enzymes, including GOT‐1, has been investigated in the erythrocytes of a 10q→24qter trisomic fetus. Analyses have been performed on a feto‐maternal blood mixture sampled by fetoscopy and on red cells obtained by cardiac puncture, following therapeutic abortion. The demonstration of a 40 percent increase of GOT‐1 activity, as compared to normal fetuses of similar gestational age, suggests that gene dosage studies may be a useful confirmatory technique in prenatal diagnosis of unbalanced chromosomal aberrations. Practical application of a similar diagnostic approach is conditioned by (1) precise characterization of fetal chromosome imbalance; (2) confirmed assignment of the gene locus coding for the gene product under investigation; (3) evidence of a linear proportionality between gene dose and concentration of the gene product in patients with the same chromosome imbalance detected in the fetus; (4) knowledge of the range of normal variation at different weeks of gestation of the enzyme activity to be tested in the fetus; (5) safety of fetal sampling procedure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom